NTLA · Intellia Therapeutics
SELL 88%
65
Total trades
17
Insiders on record
88%
Avg confidence
SELL
Signal direction
Recent insider trades
| Date | Insider | Action | Type | Value | Confidence |
|---|---|---|---|---|---|
| Mar 2, 2026 | James Basta | SELL | Open-market sale | 16.7K | 0.89 |
| Mar 2, 2026 | Eliana Clark | SELL | Open-market sale | 8.4K | 0.88 |
| Jan 5, 2026 | James Basta | SELL | Open-market sale | 95.8K | 0.93 |
| Jan 5, 2026 | Eliana Clark | SELL | Open-market sale | 87.6K | 0.93 |
| Jan 5, 2026 | David Lebwohl | SELL | Open-market sale | 109.6K | 0.95 |
| Jan 5, 2026 | Birgit C Schultes | SELL | Open-market sale | 78.4K | 0.89 |
| Jan 5, 2026 | Edward J Dulac III | SELL | Open-market sale | 58.8K | 0.95 |
| Jan 5, 2026 | Fred E Cohen | BUY | Open-market purchase | 1.4M | 0.94 |
| Jan 5, 2026 | John M Leonard | SELL | Open-market sale | 314.5K | 0.96 |
| Jan 5, 2026 | Michael P Dube | SELL | Open-market sale | 27.5K | 0.87 |
Intellia Therapeutics has 65 total insider trades on record. Sign up to see the full history, track records, and evidence trails.
Want alerts when insiders trade NTLA?
Sign up free to get notified, see the full trade history, and track insider conviction over time.
Sign up freeInsiderTrack aggregates publicly available SEC Form 4 filings. Data is provided for informational purposes only and should not be construed as investment advice. Always do your own research before making investment decisions.